Verteporfin therapy in Age-related Macular Degeneration (VAM): An open-label multicenter photodynamic therapy study of 4,435 patients

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Verteporfin therapy in Age-related Macular Degeneration (VAM): An open-label multicenter photodynamic therapy study of 4,435 patients'. Together they form a unique fingerprint.

Medicine & Life Sciences